✦ LIBER ✦

Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-stage small cell lung cancer (LS-SCLC)

✍ Scribed by Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Takatani, H; Fukuda, Mi; Soda, H; Oka, M; Kohno, S

Book ID: 118569759
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 106 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80214-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan (CPT-11) and

Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

✍ M Oka; M Fukuda; M Kuba; M Ichiki; T Rikimaru; H Soda; J Tsurutani; Y Nakamura; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

P-62 Phase II trial of irinotecan plus c

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase I study of weekly docetaxel and ci

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer

✍ Hong-Gyun Wu; Yung-Jue Bang; Eun Kyung Choi; Yong Chan Ahn; Young Whan Kim; Tae- 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

A phase I study of irinotecan and carbop

A phase I study of irinotecan and carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

✍ T. Kurata; M. Yamada; S. Kudoh; N. Yamamoto; K. Nakagawa; K. Takeda; S. Negoro; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB